Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Zhang, L. O. Cardell (Malmo, Sweden). Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation. Eur Respir J 2007; 30: Suppl. 51, 319

Member's Comments

No comment yet.

Related content which might interest you: Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Extracellular ATP triggers and maintains airway inflammation in human and murine models of asthma by activating dendritic cells Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Characterisation of endogenous IL-33 using a model of Alternaria-induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Reverbα is a novel regulator of COPD macrophage inflammation and glucocorticoid resistance Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Relationships between glutaredoxin 1 and cytokine levels in a murine model of allergic airway inflammation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013